We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $604M
1-Year Est. Return 96.57%
This Fund
S&P 500
This Quarter Est. Return
+16.87%
1 Year Est. Return
+96.57%
3 Year Est. Return
+564.25%
5 Year Est. Return
+486.18%
10 Year Est. Return
+2,856.71%
AUM
$493M
AUM Growth
+$4.13M
Cap. Flow
-$9.41M
Cap. Flow %
-1.91%
Top 10 Hldgs %
38.08%
Holding
111
New
22
Increased
19
Reduced
35
Closed
22

Top Buys

Rank Stock Value
1
CNC icon
Centene
CNC
+$13.5M
2
CI icon
Cigna
CI
+$9.96M
3
MRK icon
Merck
MRK
+$9.66M
4
ICLR icon
Icon
ICLR
+$9.38M
5
GSK icon
GSK
GSK
+$9.35M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$13.1M
2
COR icon
Cencora
COR
+$12.5M
3
WBA
Walgreens Boots Alliance
WBA
+$12.3M
4
SNY icon
Sanofi
SNY
+$10.7M
5
AMGN icon
Amgen
AMGN
+$9.2M

Sector Composition

Rank Sector Weight
1 Healthcare 90.92%
2 Miscellaneous 7.07%
3 Consumer Staples 1.34%
4 Technology 0.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRIS icon
1
Curis
CRIS
$3.61M
$49.6M 10.07%
10,954
-937
-8% -$3.92M
CI icon
2
Cigna
CI
$73.7B
$25.9M 5.25%
106,965
+44,700
+72% +$9.96M
CAH icon
3
Cardinal Health
CAH
$54.6B
$16.7M 3.39%
274,917
+119,700
+77% +$6.61M
GLD icon
4
SPDR Gold Trust
GLD
$149B
$15.5M 3.15%
97,009
-5,500
-5% -$924K
SOLY
5
DELISTED
Soliton, Inc.
SOLY
$14.5M 2.94%
824,803
-37,602
-4% -$481K
CNC icon
6
Centene
CNC
$32B
$13.9M 2.82%
+217,500
New +$13.5M
HCA icon
7
HCA Healthcare
HCA
$90.5B
$13.8M 2.8%
73,173
-7,572
-9% -$1.34M
SPRB
8
Spruce Biosciences
SPRB
$175M
$13.5M 2.74%
10,838
+2,349
+28% +$3.61M
CHRS icon
9
Coherus Oncology
CHRS
$218M
$12.4M 2.51%
847,862
-16,194
-2% -$275K
HRC
10
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$11.9M 2.41%
107,647
-15,551
-13% -$1.62M
CVM icon
11
PUT
CEL-SCI Corp
CVM
$27.4M
$10.6M 2.15%
23,190
-47,497
-67% -$25.9M
MRK icon
12
Merck
MRK
$366B
$9.64M 1.96%
+131,000
New +$9.66M
ALBO
13
DELISTED
Albireo Pharma Inc
ALBO
$9.46M 1.92%
268,346
-85,864
-24% -$3.17M
UTHR icon
14
United Therapeutics
UTHR
$22.1B
$9.37M 1.9%
56,044
+17,310
+45% +$2.89M
ICLR icon
15
Icon
ICLR
$13.1B
$9.33M 1.89%
+47,500
New +$9.38M
GSK icon
16
GSK
GSK
$102B
$9.19M 1.87%
+206,000
New +$9.35M
AMN icon
17
AMN Healthcare
AMN
$1.34B
$9.13M 1.85%
123,898
-6,700
-5% -$498K
UHS icon
18
Universal Health Services
UHS
$10.1B
$9.09M 1.84%
68,135
-12,708
-16% -$1.69M
EPIX
19
DELISTED
ESSA Pharma
EPIX
$9.08M 1.84%
312,711
-120,312
-28% -$2.8M
MIRM icon
20
Mirum Pharmaceuticals
MIRM
$5.94B
$8.66M 1.76%
437,138
-57,605
-12% -$1.1M
BLRX
21
BioLineRX
BLRX
$11.4M
$7.65M 1.55%
+68,544
New +$8.24M
MCK icon
22
McKesson
MCK
$104B
$7.59M 1.54%
38,893
-8,569
-18% -$1.56M
XFOR icon
23
X4 Pharmaceuticals
XFOR
$401M
$6.93M 1.41%
+26,820
New +$7.05M
HLF icon
24
Herbalife
HLF
$1.3B
$6.6M 1.34%
148,719
+71,059
+92% +$3.5M
RCOR
25
DELISTED
Renovacor, Inc.
RCOR
$6.41M 1.3%
+600,000
New +$6.21M

Similar funds

Sio Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Sio Capital Management held 111 positions worth $493M, up 0.85% from $489M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Sio Capital Management's Q1 2021 filing shows 22 new, 19 increased, 35 reduced and 22 closed positions. Its largest new stake was Centene: 217,500 shares worth $13.9M. The largest sale was AstraZeneca, an estimated $13.1M.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, up from 86% a quarter earlier, followed by Miscellaneous and Consumer Staples.

  • Sio Capital Management's largest Q1 2021 buy was Centene: 217,500 shares worth $13.9M.
  • Sio Capital Management added most to Cigna in Q1 2021, an estimated $9.96M increase.
  • Sio Capital Management's biggest Q1 2021 reduction was Curis, cutting an estimated $3.92M.
  • Sio Capital Management fully exited AstraZeneca in Q1 2021, selling an estimated $13.1M.
  • Sio Capital Management's ten largest holdings make up 38% of its $493M portfolio in Q1 2021.
  • Sio Capital Management opened 22 new positions and closed 22 in Q1 2021.
  • Sio Capital Management's portfolio value rose 0.85% quarter-over-quarter to $493M.

Based on Sio Capital Management's 13F filing for Q1 2021, filed 14 May 2021.